PsychoGenics

Tarrytown, United States Founded: 1999 • Age: 27 yrs
Preclinical CRO services for CNS and orphan disorders are offered.
Annual revenue - Latest available
Total funding - 6 rounds
Employees 124 Tracked headcount
Investors 2 Known backers
Products 3 Services tracked
Competitors 10 Brand Intelligence

About PsychoGenics

PsychoGenics is a company based in Tarrytown (United States) founded in 1999. The company has 124 employees as of December 31, 2020. PsychoGenics offers products and services including eCube™, NeuroCube®, and Behavioral Testing. PsychoGenics operates in a competitive market with competitors including TransCure bioServices, GenOway, PharmaLegacy Laboratories, InVivo Biosystems and Noble Life Sciences, among others.

  • Headquarter Tarrytown, United States
  • Employees 124 as on 31 Dec, 2020
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $3 M (USD), Grant

    Aug 28, 2024

  • Investors
    NIH

    & 1 more

  • Employee Count
    124

    as on Dec 31, 2020

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of PsychoGenics

PsychoGenics offers a comprehensive portfolio of products and services, including eCube™, NeuroCube®, and Behavioral Testing.

Product name locked
Category locked
Primary

AI tool for neuropsychiatric drug discovery and testing

Product name locked
Category locked
Locked

Platform for analyzing neurological disorders in research

Product name locked
Category locked
Locked

In vivo testing for efficacy in CNS disorder models

People of PsychoGenics

Headcount 50-200
Employee Profiles 27
Board Members and Advisors 11
Employee Profiles
People
Gregory Berger
Associate Scientist
People
Cindy Hsu
General Counsel
People
Herman B. Fernandes
Associate Director, Mouse Pharmacology & Electrophysiology
People
Dani Brunner
Chief Innovation Officer

Unlock access to complete

Funding Insights of PsychoGenics

Investors in PsychoGenics

PsychoGenics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NIH and HHS.

All
Institutional
Investor Description Founded Year Domain Location
Drug discovery services are provided to the biopharma sector.
Locked Locked Locked
Public health and human services are overseen by HHS.
Locked Locked Locked
Premium access

Investor details for PsychoGenics

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by PsychoGenics

Investments
Premium access

Investment portfolio details for PsychoGenics

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - PsychoGenics

Premium access

Detailed financials for PsychoGenics

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Psychogenics Comparisons

PsychoGenics Primary company
Description
Preclinical CRO services for CNS and orphan disorders are of...
Location
Tarrytown, United States
Founded Year
1999
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
124
As of 2020
Premium access

Peer comparison for PsychoGenics

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of PsychoGenics

PsychoGenics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TransCure bioServices, GenOway, PharmaLegacy Laboratories, InVivo Biosystems and Noble Life Sciences, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Humanized mouse models are developed for preclinical immune drug studies.
Locked Locked Locked
Provider of transgenic rodent models and customized cell lines for preclinical development
Locked Locked Locked
Preclinical CRO offering in vivo models and services for a wide range of therapeutic areas
Locked Locked Locked
Animal models are supplied for in-vivo analytical services.
Locked Locked Locked
Preclinical contract research organization offering standard GLP and non-GLP services
Premium access

Detailed competitors of PsychoGenics

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Psychogenics

Premium access

Complete news archive for PsychoGenics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about PsychoGenics

PsychoGenics was founded in 1999 and raised its 1st funding round 8 years after it was founded.

PsychoGenics is headquartered in Tarrytown, United States. It is registered at Tarrytown, New York, United States.

As of Dec 31, 2020, the latest employee count at PsychoGenics is 124.

Psychogenics offers drug discovery capabilities for companies focusing on CNS and orphan disorders psychiatric and neurodegenerative disorders, pain and inflammation, spinal cord and traumatic brain injury. PsychoGenics capabilities include behavioral testing, electrophysiology, molecular biology, microdialysis and a variety of in-licensed transgenic mouse models. PsychoGenics technologies have been developed to facilitate high throughput, in vivo, compound screening. It facilitates drug discovery by combining expertise in behavioral neurobiology, bioinformatics and behavioral testing platforms, that can rapidly screen compound libraries for CNS activity.

PsychoGenics's top competitors include GenOway, Alpha Genesis and PharmaLegacy Laboratories.

PsychoGenics offers eCube™, NeuroCube®, and Behavioral Testing.

PsychoGenics has 2 investors. Key investors include NIH, and HHS.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available